Notably, in human breast cancers, the expression of CXCL9/10/11 shows strong positive associations with CD8 expression (used as a surrogate for intratumoral T-cell content), which is consistent with a recent study (Supplementary Fig. 12a, b)1. Here, CXCL9 is linked to breast carcinoma.